Psychiatry

Use of benzodiazepines or benzodiazepine-like hypnotics should only occur during pregnancy after a thorough evaluation of the benefits and risks for the mother and child.

A trio of clinicians discuss what needs to occur for telemedicine to be seen as a positive in reducing burnout during the ongoing pandemic.

Many tools are becoming available to psychiatrists who need to strengthen their reach of care outside the office.

In the last 20 years suicide rates have increased substantially, while emergency department visits for suicidal ideation and suicide attempts have doubled.

Individuals at 15 years old with depression experience struggles with both sleep patterns and sleep quality.

ADHD symptoms are highly comorbid with insomnia, restless leg syndrome, and snoring.

Antipsychotics commonly cause a number of side effects including weight gain and long-term cardiovascular disease.

Cardiovascular events and death increased by 20% in people with 4 or more depressive symptoms compared to individuals without depressive symptoms.

An analysis of nearly 8k veterans has found use of metformin was associated with a reduction in PTSD symptoms.

In multiple clinical trials, investigators do not find any serious adverse events.

Association with familial history found in hospitalizations, suicide attempts, and an earlier onset of symptoms.

Survey findings highlight the psychological and psychosocial distress related to having diabetes.

Time of cannabis use can predict larger decreases in intrusions and irritability in individuals suffering from PTSD.

Other treatment plans need to be considered for women with anxiety or insomnia.

Prior coronavirus outbreaks help assess the possible psychiatric dangers related to COVID-19.

High-potency cannabis use led to an increase in cannabis use frequency, as well as cannabis problems.

Investigators expect an increase in demand for mental health services for young people in the coming years.

More prospective studies are needed to examine how different drugs can be effective for schizophrenia patients based on the cluster of symptoms.

Antipsychotic discontinuation remains a major hurdle for effective schizophrenia treatment.

The tau tracer can support a pathological diagnosis of Alzheimer disease by identifying the underlying presence of NFTs at the B3 level.

The results of a phase 3B study show the medication is effective treating the disorder despite only needing to be taken once every 8 weeks.

In a new study, investigators discover insomnia severity could predict first-onset major depressive disorder.

The new technology has applications for diagnosis and recruitment for disease-modifying trials.

In the latest edition of the DocTalk Podcast, Dr. Mark Smith talks about some of the issues related to the COVID-19 lockdown and how a second wave might psychologically impact individuals.

Older age and higher educational level were associated with only the conditional probability of an individual treatment professional being perceived as helpful.